Threshold Pharmaceuticals (United States) (Q332167)

company organization in San Francisco, United States

Language	Label	Description	Also known as
English	Threshold Pharmaceuticals (United States)	company organization in San Francisco, United States

Statements

instance of

company

0 references

addresses subject

Metabolic Reprogramming in Cancer Biology

prevalence

91

1 reference

reference URL

https://openalex.org/I4210106184

Engineering Bacteria for Cancer Treatment

prevalence

21

1 reference

reference URL

https://openalex.org/I4210106184

Nanotechnology and Imaging for Cancer Therapy and Diagnosis

prevalence

18

1 reference

reference URL

https://openalex.org/I4210106184

Genomic Landscape of Cancer and Mutational Signatures

prevalence

18

1 reference

reference URL

https://openalex.org/I4210106184

Pancreatic Cancer Research and Treatment

prevalence

14

1 reference

reference URL

https://openalex.org/I4210106184

Advancements in Lung Cancer Research

prevalence

13

1 reference

reference URL

https://openalex.org/I4210106184

Diagnosis and Treatment of Multiple Myeloma

prevalence

10

1 reference

reference URL

https://openalex.org/I4210106184

Small Cell Lung Cancer

prevalence

10

1 reference

reference URL

https://openalex.org/I4210106184

Epigenetic Modifications and Their Functional Implications

prevalence

10

1 reference

reference URL

https://openalex.org/I4210106184

Neuroblastoma Research and Treatment

prevalence

9

1 reference

reference URL

https://openalex.org/I4210106184

The p53 Signaling Network in Cancer Research

prevalence

9

1 reference

reference URL

https://openalex.org/I4210106184

Gliomas

prevalence

9

1 reference

reference URL

https://openalex.org/I4210106184

Sarcoma Research and Treatment

prevalence

9

1 reference

reference URL

https://openalex.org/I4210106184

Targeted Protein Degradation in Biomedical Research

prevalence

8

1 reference

reference URL

https://openalex.org/I4210106184

DNA Topoisomerases: Structure, Function, and Inhibition

prevalence

8

1 reference

reference URL

https://openalex.org/I4210106184

Ubiquitin-Proteasome Proteolytic Pathway

prevalence

6

1 reference

reference URL

https://openalex.org/I4210106184

RNA Methylation and Modification in Gene Expression

prevalence

6

1 reference

reference URL

https://openalex.org/I4210106184

Vascular Tumors and Angiosarcoma

prevalence

5

1 reference

reference URL

https://openalex.org/I4210106184

Hepatocellular Carcinoma

prevalence

5

1 reference

reference URL

https://openalex.org/I4210106184

Acute Myeloid Leukemia

prevalence

5

1 reference

reference URL

https://openalex.org/I4210106184

Hematopoietic Stem Cell Biology

prevalence

4

1 reference

reference URL

https://openalex.org/I4210106184

Epidemiology and Treatment of Childhood Leukemia

prevalence

4

1 reference

reference URL

https://openalex.org/I4210106184

Molecular Mechanisms of Kidney Development and Disease

prevalence

4

1 reference

reference URL

https://openalex.org/I4210106184

Mitochondrial Dynamics and Reactive Oxygen Species Regulation

prevalence

4

1 reference

reference URL

https://openalex.org/I4210106184

Renal Cell Carcinoma

prevalence

3

1 reference

reference URL

https://openalex.org/I4210106184

coordinate location

37°39'11"N, 122°24'3"W

1 reference

reference URL

https://openalex.org/I4210106184

country

United States of America

1 reference

reference URL

https://openalex.org/I4210106184

official website

http://www.thresholdpharm.com/

1 reference

reference URL

https://openalex.org/I4210106184

OpenAlex ID

I4210106184

0 references

Research Organization Registry ID

02bb3e325

0 references

Anonymous

Search

Threshold Pharmaceuticals (United States) (Q332167)

Namespaces

More

Page actions

Statements

Navigation

Navigation

Wikibase

Wiki tools

Wiki tools

Anonymous

Search

Threshold Pharmaceuticals (United States) (Q332167)

Statements

Navigation

Wiki tools

Page tools

Other projects